Projects per year
Fingerprint
Dive into the research topics where Matthew Philip Goetz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
-
-
Mayo Clinic Breast Cancer SPORE
Chen, J., Couch, F. J., Gendler, S. J., Ingle, J. N., Lingle, W. L., Suman, V. J., Vachon, C. M., Goetz, M. P., Degnim, A. C., Vachon, C. M., Galanis, E., Haluska, P. R. J., Hawse, J. R., Carter, J., Chen, J. J., Sherman, M. E., Visscher, D. W. & Wang, L. M.
9/22/05 → 8/31/24
Project: Research project
-
-
Automated mitotic spindle hotspot counts are highly associated with clinical outcomes in systemically untreated early-stage triple-negative breast cancer
Leon-Ferre, R. A., Carter, J. M., Zahrieh, D., Sinnwell, J. P., Salgado, R., Suman, V. J., Hillman, D. W., Boughey, J. C., Kalari, K. R., Couch, F. J., Ingle, J. N., Balkenhol, M., Ciompi, F., van der Laak, J. & Goetz, M. P., Dec 2024, In: npj Breast Cancer. 10, 1, 25.Research output: Contribution to journal › Article › peer-review
Open Access -
Identification of a Notch transcriptomic signature for breast cancer
Braune, E. B., Geist, F., Tang, X., Kalari, K., Boughey, J., Wang, L., Leon-Ferre, R. A., D’Assoro, A. B., Ingle, J. N., Goetz, M. P., Kreis, J., Wang, K., Foukakis, T., Seshire, A., Wienke, D. & Lendahl, U., Dec 2024, In: Breast Cancer Research. 26, 1, 4.Research output: Contribution to journal › Article › peer-review
Open Access -
Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+/Her2- breast cancer
Moldoveanu, D., Hoskin, T. L., Day, C. N., Schulze, A. K., Goetz, M. P. & Boughey, J. C., Feb 2024, In: Breast Cancer Research and Treatment. 203, 3, p. 419-428 10 p.Research output: Contribution to journal › Review article › peer-review
-
Patient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer
Alkhatib, H., Conage-Pough, J., Roy Chowdhury, S., Shian, D., Zaid, D., Rubinstein, A. M., Sonnenblick, A., Peretz-Yablonsky, T., Granit, A., Carmon, E., Kohale, I. N., Boughey, J. C., Goetz, M. P., Wang, L., White, F. M. & Kravchenko-Balasha, N., Dec 2024, In: Molecular cancer. 23, 1, 17.Research output: Contribution to journal › Letter › peer-review
Open Access -
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
monarchE Committee Members, Jan 2023, In: The Lancet Oncology. 24, 1, p. 77-90 14 p.Research output: Contribution to journal › Article › peer-review